title: Response to Calcagno comment on "Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid".
authors.affiliation: *Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland †Department of Infectious Diseases, University Hospital Bern, Bern, Switzerland ‡Division of Clinical Pharmacology, University Hospital Centre and University of Lausanne, Lausanne, Switzerland.
authors.forename: Alexia
authors.initials: A
authors.lastname: Cusini
authors.forename: Bruno
authors.initials: B
authors.lastname: Ledergerber
authors.forename: Nicolas
authors.initials: N
authors.lastname: Widmer
authors.forename: Huldrych F
authors.initials: HF
authors.lastname: Günthard
mesh_terms: D044966:Anti-Retroviral Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D002555:Cerebrospinal Fluid / Q000821:virology*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D019562:Viral Load
chemical_list: D044966:Anti-Retroviral Agents